National Cancer Registry

Definition	A cancer registry is defined as a location, be it an office or institution, where collection, storage, analysis and interpretation of data on cancer patients take place (Jenson et al, 1991).
Objectives	- To measure cancer incidence - To describe cancer by time, place, persons and disease - To provide a national database for further epidemiological research
Case definition	Target cases are: - Incident cases by year of diagnosis - Malignant tumors confirmed by histopathology and/or hematology findings - Cancers of all sites
Sources of data	Data are collected through two main channels: the capture system (passive reporting) and the recapture system (active reporting). 1) The capture system: The capture system is based on physician’s routine reporting of cancer cases. Physician’s complete and send forms: - Directly from their clinic; or - Indirectly through the MOPH Drug Dispensing Center (DDC), where anti-cancer drugs are distributed to eligible patients 2) The recapture system: The recapture system is based on gathering information directly from histopathological and hematological laboratories. Data are collected in various ways, using hard or soft copies, or using database file or individual laboratory results depending on laboratories resources. This process is active since the NCR personnel actually contact the sites to obtain the necessary data. The recapture system validates and complements the capture approach.
Medical coding	The coding of cancer primary sites and cancer morphology is done using International Classification of Diseases for Oncology, third edition (ICD-O-3). The code includes information on the topography (primary site), the histology, the behavior and the grade of the tumor. The structure is C##.# M####/##, where: - C##.# specifies the primary site - M#### specifies the histology - /## specifies the behavior and the grade of the tumor
Reporting form	NCR reporting form

ATC	Name	B/G	Ingredients	Form	Price
D07XA01	DAKTACORT	B	Hydrocortisone - 10mg/g, Miconazole nitrate - 20mg/g	Cream	208,296 L.L
A02BC	DANLOX QUICK	G	Omeprazole - 20mg, Sodium bicarbonate - 1680mg	Powder	1,323,685 L.L
D07XC01	DIPROSALIC	B	Salicylic acid - 30mg/g, Betamethasone (dipropionate) - 0.5mg/g	Ointment	352,087 L.L
R03AL02	DUOLIN RESPULES	G	Salbutamol (sulfate) - 2.5mg/2.5ml, Ipratropium bromide (monohydrate) - 500mcg/2.5ml	Inhaltion solution with nebuliser	417,935 L.L
J07CA11	DIPHTHERIA, TETANUS,PERTUSSIS, HEPATITIS B AND HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE	B	Diphteria Toxoid1 - ?25Lf (?30IU)/0.5ml, Tetanus toxoid1 - ?2.5Lf (?40IU)/0.5ml, Bordetella pertussis (Whole cell) - ?16OU (?4.0IU)/0.5ml, HBs Antigen (r DNA)1 - ?10mcg/0.5ml, H. Influenza type b, purified capsular polysaccharide2 - 10mcg/0.5ml, 1 adsorbed on aluminium phosphate, Al+++ - ?1.25mg , 2 conjugated to tetanos toxoid carrier protein -	Injectable suspension	1,515,854 L.L
B05CX01	DEXTROSE INJECTION 5%	G	Dextrose, H2O - 5g/100ml	Injectable solution	212,797 L.L
S01CA01	DEXATOBRIN	G	Dexamethasone - 1mg/ml, Tobramycin - 3mg/ml	Drops suspension	239,204 L.L
M01BX	DORIXINA B1B6B12	B	Lysine clonixinate - 125mg, Vitamin B1 - 50mg, Vitamin B6 - 30mg, Vitamin B12 - 50mcg	Tablet, film coated	804,962 L.L
D10AF51	DUAC ONCE DAILY	B	Clindamycin (phosphate) - 1%, Benzoyl peroxide - 5%	Gel	1,658,302 L.L
C05BX51	DOXIPROCT	B	Calcium dobesilate - 4%, Lidocaine HCl - 2%	Ointment	610,104 L.L
C05BX51	DOXIPROCT PLUS	B	Calcium dobesilate - 4%, Dexamethasone acetate - 0.0025%, Lidocaine HCl - 2%	Ointment	489,159 L.L
G04CA52	DUTAMSUVITAE	G	Tamsulosin HCl - 0.4mg, Dutasteride - 0.5mg	Capsule, hard	2,168,962 L.L
G04CA52	DUTASTERIDE/TAMSULOSINE ARROW	G	Tamsulosin HCl - 0.4mg, Dutasteride - 0.5mg	Capsule	1,337,123 L.L
C05CA53	DAFLON	B	Hesperidin - 50mg, Diosmin - 450mg	Tablet, film coated	627,574 L.L
B05DB	DIANEAL PD4 CYCLER 1.36% GLUCOSE	B	Sodium lactate - 4.48g/l, Magnesium chloride - 0.051g/l, Calcium chloride - 0.184g/l, Sodium chloride - 5.38g/l, Anhydrous glucose - 13.6g/l	Injectable solution	1,150,329 L.L
C05CA53	DAFLON	B	Hesperidin - 50mg, Diosmin - 450mg	Tablet, film coated	1,191,988 L.L
N06CA02	DEANXIT	B	Flupentixol (dihydrochloride) - 0.5mg, Melitracen (HCl) - 10mg	Tablet, film coated	1,372,063 L.L
B05DB	DIANEAL PD4 2.27% GLUCOSE	B	Sodium lactate - 4.48g/l, Magnesium chloride - 0.051g/l, Calcium chloride - 0.184g/l, Sodium chloride - 5.38g/l, Anhydrous glucose - 22.7g/l	Injectable solution	1,163,270 L.L
C05CA53	DAFLON	B	Hesperidin - 100mg, Diosmin - 900mg	Tablet, film coated	1,256,493 L.L
B05DB	DIANEAL PD4 CYCLER 2.27% GLUCOSE	B	Sodium lactate - 4.48g/l, Magnesium chloride - 0.051g/l, Calcium chloride - 0.184g/l, Sodium chloride - 5.38g/l, Anhydrous glucose - 22.7g/l	Injectable solution	1,150,329 L.L
B05DB	DIANEAL PD4 3.86% GLUCOSE	B	Sodium lactate - 4.48g/l, Magnesium chloride - 0.051g/l, Calcium chloride - 0.184g/l, Sodium chloride - 5.38g/l, Anhydrous glucose - 38.6g/l	Injectable solution	1,111,506 L.L
B05DB	DIANEAL PD4 CYCLER 3.86% GLUCOSE	B	Sodium lactate - 4.48g/l, Magnesium chloride - 0.051g/l, Calcium chloride - 0.184g/l, Sodium chloride - 5.38g/l, Anhydrous glucose - 38.6g/l	Injectable solution	1,150,329 L.L
S01ED51	DORZOLAMIDE/TIMOLOL BGR	G	Timolol maleate - 5mg/ml, Dorzolamide HCl - 20mg/ml	Drops solution	689,391 L.L
S01ED51	DORZOPTIC PLUS	G	Timolol - 0.5%, Dorzolamide HCl - 2%	Drops solution	548,288 L.L
N02BE51	DIFEN GESIC	G	Paracetamol - 400mg, Diclofenac potassium - 50mg	Tablet, film coated	330,585 L.L
N02BE51	DOLFEIN	G	Paracetamol - 400mg, Caffeine - 50mg, Codeine phosphate hemihydrate - 20mg	Tablet	249,571 L.L
S01ED51	DUOTRAV	B	Timolol (maleate) - 5mg, Travoprost - 40mcg	Drops solution	1,933,789 L.L
M03BA53	DISTEM	G	Paracetamol - 300mg, Methocarbamol - 380mg	Tablet	978,317 L.L
B03BA51	DEPOVEX	B	Aluminium monostearate - 20mg/ml, Cyanocobalamine - 1mg/ml	Injectable oily suspension	423,310 L.L
M03BX	DORIXINA RELAX	B	Lysine clonixinate - 125mg, Cyclobenzaprine HCl - 5mg	Tablet, film coated	581,884 L.L

National Cancer Registry (NCR)